Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 376-400 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
moderate COVID-19
Design:
This is a parallel 2-arm randomized, controlled, double-blind, single center (...) will be blinded
Participants/Inclusion and exclusion criteria:
All mild to moderate COVID-19 infected (...) breastfeeding, any prior experimental treatment for COVID-19, taking Amiodarone and Rifampin, evidence of
clinical and laboratory symptoms in patients with Covid-19: Clinical trial
Design:
The clinical trial has (...) number assigned to each patient.
Settings and conduct:
In Razi Hospital, Ahvaz, two groups of Covid-19(...) confirmation of Covid19 based on PCR results and approved global health clinical signs confirmed by a
Study aim:
Clinical trial of the effects of elderberry extract syrup against COVID-19 symptoms in outpatients and home quarantined patients
Design:
This is a randomized, double-blinded, placebo controlled (...) quarantined patients. 40 patients with COVID-19 disease will be selected and randomly assigned to two groups
manifestations of patients with probable or confirmed COVID-19
Design:
This pilot clinical trial will be performed on 15 hospitalized patients with probable or confirmed COVID-19, as before-after trial without (...) assigned for COVID-19 patients. This research will be carried out in April of 2020.
Participants/Inclusion
Study aim:
Evaluation the effect of crocetin in improving the clinical and laboratory symptoms of patients with COVID-19
Design:
A randomized, blinded, placebo-controlled clinical trial
with a parallel (...) study will be performed on outpatients. In this study,
40 patients with COVID-19 disease were selected
Study aim:
Comparing safety and efficacy of Favipiravir and Kaletra in COVID-19
Design:
In this (...) criteria:
Inclusion criteria: Diagnosis of COVID-19 based on either ground glass appearance in chest CT scan or positive RT-PCR test for COVID-19; Requiring hospitalization; Patient's age between 16 and 100
moderate COVID-19
Design:
This is a non-randomized open label, parallel group clinical trial on 60 patients with mild to moderate covid-19 (30 patients in treatment group and 30 patients in control (...) to moderate covid-19 who refer to Sharif Clinic, Mashhad, Iran. They whether will received two
:
Laboratory confirmed COVID-19 with RT-PCR, Age over 18 years old, Oxygen saturation < 93%, Fever more than 72 (...) of COVID-19 Critical phase of COVID-19 and Pancreatitis
Intervention groups:
In this study, patients (...) Study aim:
Evaluation the efficacy and safety of Sitagliptin administration in patients with COVID
forms of covid-19 virus
Design:
Randomized controlled trial study; double-blind; parallel groups; on (...) symptoms of covid-19 disease
Do not have positive test
Intervention groups:
Intervention Group is500 (...) outcome variables:
- COVID-19 Mild type (fever - cough - shortness of breath and positive PCR
test
Study aim:
Determination of the grapefruit seed extract efficacy in the treatment of COVID-19 as an (...) volunteer patients with COVID-19 at Masih Daneshvari Hospital in Tehran confirmed by PCR. Patients (...) above 18 and under 60 years old, that their COVID-19 is confirmed by PCR test, and don't have any
COVID-19
Design:
This is a randomized triple-blind, parallel group clinical trial on 40 patients with mild to moderate covid-19 (20 patients in treatment group and 20 patients in placebo group).
Settings (...) moderate covid-19 who refer to Quem Hospital, Mashhad, Iran. They whether will received one colchicine 1mg
Study aim:
Investigating the efficacy and safety of Nivasha oral spray in controlling the symptoms of patients with COVID-19
Design:
This study is a multi-center, prospective, randomized, open (...) cough, shortness of breath, fever) confirm COVID-19. Confirmed diagnosis of COVID-19, with RT-PCR
Study aim:
A- Finding effective and available treatment for COVID-19 patients
B- Comparison of our (...) double blind clinical trial
Settings and conduct:
Hospitalized COVID-19 positive patients will be (...) and exclusion criteria:
All of the COVID-19 hospitalized patients with positive PCR and Chest CT-scan
coronavirus pneumonia (COVID-19)
Design:
A randomized controlled clinical trial with parallel groups (...) Department of Health for Covid-19, are a quarantine candidate and receive home treatment.
Participants/Inclusion and exclusion criteria:
patients with 18-65 years old, developing mild to moderate COVID-19 based
covid-19
Design:
Phase 3,2 arms each arms 50 patients, block randomization
Two arm parallel group (...) criteria:
Inclusion criteria:
-age>18
-Patients with probable and definitive diagnosis of covid-19(...) or imaging findings for covid-19
Exclusion criteria:
-Patients or companion dissatisfaction to enter
Study aim:
Evaluation the effect of lithium carbonate in covid-19 patients
Design:
A randomized, blinded, placebo controlled clinical trial with a parallel group design of 40 patients, randomizing with (...) this study, 40 patients with covid-19 disease were selected and randomly assigned to two groups of 20
patients with COVID-19 infection
Design:
The study is a non-randomized, single-blind clinical trial (...) university Tehran Medical Sciences on hospitalized COVID-19 patients. Patients are treated in intervention (...) and exclusion criteria:
Inclusion criteria: Older than 18 years old, Hospitalized with COVID-19
respiratory failure as well as organs failure and death of COVID-19 disease.
Design:
Clinical trial with parallel control group , randomisation by balanced block method, phase 2 on 60 COVID-19 patients
Settings and conduct:
60 COVID-19 patients admitted to Tabriz Imam Reza Hospital will be divided in 2
the control group will receive the hospital's standard protocol for the treatment of COVID-19. The (...) diagnosed with COVID-19 using the RT-PCR test
- having a breathing rate> 30 per minute
- Arterial blood (...) burden associated with ARDS, mortality, and the need for hospitalization in patients diagnosed with COVID
micrograms/Kg once every other day for 3 doses plus the usual national protocol of treatment for COVID-19(...) analyzed using SPSS software.
Settings and conduct:
In this study, 25 patients with COVID19 being (...) criteria:
50 patients with COVID19 disease with no exclusion criteria
Exclusion criteria:
history of
covid-19 who referred to Booali Hospital in Tehran in 2023
Design:
The clinical trial, with parallel (...) criteria:
All those who have been infected with Covid-19 for more than 6 months
Noticeable hair loss
Age 20 (...) treatment of hair loss patients with a history of covid-19
with covid-19 (Coronavirus 19 disease)
Design:
This clinical trial has control group, and with (...) exclusion criteria:
Inclusion criteria:
Male or female patients 18 years old and older with COVID-19,
positive coronavirus 19 PCR,
Ground glass view at low-dose CT scan,
Arterial oxygen saturation less than 93
Study aim:
Determining the effect of eye movements desensitization and reprocessing in real and virtual methods and comparing them on fear of COVID19 in nurses
Design:
Controlled clinical trial, with (...) (eye movements desensitization and reprocessing) on fear of covid19
Study aim:
Evaluation of thrombolytic and anticoagulant in treatment of COVID-19 patients
Design:
This study is a randomized control trial with tree arm parallel group without double blind. We have (...) :
Critical COVID patients with d.Dimer more than 3000 ng/ml
Intervention groups:
The patients will started
treatment of prolonged anosmia and hyposmia in patients with Covid-19
Design:
Clinical trial without (...) and 60 years
Loss of sense of smell after Covid-19 (anosmia or hyposmia that has not improved for more (...) prolonged diminished or loss of sense of smell after Covid19 disease receive four sessions of TDCS